In the pancreatic tumor microenvironment, CD8+ T cells were found to blockade PD-1 checkpoints and CXCR4 to exert an antitumor effect, suggested the promising objectives of immunotherapies (Seo et al., 2019). Here, CD8A is linked to pancreatic neoplasm.